Company / Operating Cash Flow per Share
Valion Bio, Inc. Operating Cash Flow per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$98.69
FY2024
5-year range
-$98.69 / -$0.58
FY2022-FY2024
Trend
-7.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.58 to $-98.69 over the past 2 years.
Based on SEC 10-K filings.
-98.69 in FY2024.
Declined from $-0.58 to $-98.69 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow per share decreased 7.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$98.69 | -7.1% |
| FY2023 | -$92.16 | -15854.2% |
| FY2022 | -$0.58 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026